Hypophosphatemia after High Dosage Iron Substitution with Ferric Carboxymaltose (FCM) and Iron Isomaltoside (IM) — the Randomised Controlled Home Afers 1 Trial

• Published in: Blood Vol. 132; no. Supplement 1; p. 3627
• Main Authors: Emrich, Insa E., Lizzi, Fabio, Sarah, Seiler-Mußler, Ukena, Christian, Kaddu-Mulindwa, Dominic, Böhm, Michael, Stilgenbauer, Stephan, Fliser, Danilo, Brandenburg, Vincent, Heine, Gunnar
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 29.11.2018

In iron deficiency anaemia patients, intravenous administration of either ferric carboxymaltose (FCM) or iron isomaltoside (IM) both allow high dosage iron substitution within a single outpatient visit. In contrast, other iron compounds require repetitive, low dosage infusions. Recently, FCM was rep...